Gilead’s long-acting…
Gilead’s long-acting pre-exposure prophylaxis med Yeztugo has garnered $54 million [...]
Takeda tightened its pipeline in…
Takeda tightened its pipeline in the third quarter. Innovent Biologics [...]
As Biogen continues to carve out…
As Biogen continues to carve out new markets for its [...]
With vaccine sales on the decline…
With vaccine sales on the decline across the industry, these [...]
Bristol Myers Squibb’s highly…
Bristol Myers Squibb’s highly anticipated Cobenfy just finished its first [...]
Despite the largest U.S. pharmacy…
Despite the largest U.S. pharmacy benefit manager knocking Zepbound off [...]
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs
The agency announced moves to cut regulatory obstacles for the [...]
The FDA has revealed a set of…
The FDA has revealed a set of measures designed to [...]
After a progression-free survival…
After a progression-free survival win last year raised hopes for [...]
Texas Sues Tylenol Makers, Claiming They Hid Autism Risks
The lawsuit follows claims by President Trump that linked use [...]